Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Human CRACC (SLAMF7) Fc Chimera Recombinant Protein

Click to view available options
Quantity:
1 mg
100 μg
Description
It is recommended that the protein be aliquoted for optimal storage. It is recommended that sterile water (4762 μL) be added to the vial to prepare a stock solution of 0.25 mg/mL. Concentration is measured by UV.
SLAMF7 contains one Ig-like C2-type (immunoglobulin-like) domain. Isoform 1 mediates NK cell activation through a SAP-independent extracellular signal-regulated ERK-mediated pathway. It may play a role in lymphocyte adhesion. Isoform 3 does not mediate any activation. SAP can bind the cytoplasmic tail of isoform 1 when phosphorylated in the presence of Fyn (in vitro). SLAMF7 is expressed in spleen, lymph node, peripheral blood leukocytes, bone marrow, small intestine, stomach, appendix, lung and trachea. Expression was detected in NK cells, activated B-cells, NK-cell line but not in promyelocytic, B-, or T-cell lines. The isoform 3 is expressed at much lower level than isoform 1. There are three named isoforms.

Specifications
Specifications
Accession Number | Q9NQ25 |
Concentration | 0.25 mg/mL |
For Use With (Application) | Control |
Format | Lyophilized |
Formulation | PBS with 0.01% Tween 80, 5% mannitol, 5% trehalose and no preservative; pH 7.4 |
Gene ID (Entrez) | 57823 |
Molecular Weight (g/mol) | 49.1 kDa |
Name | Human CRACC (SLAMF7) Fc Chimera |
Purification Method | SDS-PAGE |
Quantity | 100 μg |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction